Micafungin 100 MG Injection — RxCUI 861383
RxNorm drug concept · Semantic clinical drug
RxCUI 861383
Semantic clinical drug · SCD
● Current RxNorm concept 24 FDA products
40 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI861383
Official nameMicafungin 100 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmicafungin 100 MG (equivalent to micafungin sodium 101.73 MG) Injection; micafungin sodium 100 MG Injection
FDA products mapped24
Package NDCs mapped40
Reported Medicaid activity (SDUD)8,044 prescriptions · 37 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Micafungin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Micafungin only comes in an injectable form — there's no tablet or capsule version. It's given directly into your vein through an IV so it gets into your bloodstream quickly and at...
- Why am I getting this medication through an IV instead of taking a pill?
- That depends on which infection you have. For bloodstream or other invasive Candida infections, treatment typically lasted around 15 days on average in clinical trials, though it c...
- How long will I need to be on micafungin?
🕸️ Concept Web — How Micafungin 100 MG Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Micafungin 100 MG Injection
RxCUI 861383 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Micafungin
325887IN
-
Micafungin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Mycamine
583520BN
-
Mycamine
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Micafungin Injection
1722943SCDF -
Micafungin Injectable Product
1156756SCDG -
Micafungin Injection [Mycamine]
1722946SBDF -
Mycamine Injectable Product
1184404SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Micafungin Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Micafungin 100 MG
2670393SCDC -
Micafungin 100 MG Injection [Mycamine]
861385SBD -
Micafungin 100 MG [Mycamine]
2670395SBDC
-
Micafungin 100 MG
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Micafungin 100 MG
SCDC · 2670393 -
Micafungin Injection
SCDF · 1722943 -
Micafungin Injectable Product
SCDG · 1156756
Brand-Name Concepts
-
Micafungin 100 MG Injection [Mycamine]
SBD · 861385 -
Micafungin 100 MG [Mycamine]
SBDC · 2670395 -
Micafungin Injection [Mycamine]
SBDF · 1722946 -
Mycamine Injectable Product
SBDG · 1184404 -
Mycamine
BN · 583520
📦 FDA Products & Package NDCs
24 products · 40 package NDCs
40 package NDCs map to RxCUI 861383 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00143-9361-01 | 1 VIAL in 1 CARTON (0143-9361-01) / 5 INJECTION, POWDER, LY... | Micafungin | Hikma Pharmaceuticals USA Inc. | 2021-07-09 |
| 00143-9362-01 | 1 VIAL in 1 CARTON (0143-9362-01) / 5 INJECTION, POWDER, LY... | Micafungin | Hikma Pharmaceuticals USA Inc. | 2021-07-09 |
| 00469-3250-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0469-3250-10) / 5 mL in 1... | Mycamine | Astellas Pharma US, Inc. | 2005-03-16 |
| 25021-0190-10 | 1 VIAL in 1 CARTON (25021-190-10) / 5 mL in 1 VIAL | Micafungin | Sagent Pharmaceuticals | 2021-06-15 |
| 25021-0190-11 | 10 VIAL in 1 CARTON (25021-190-11) / 5 mL in 1 VIAL | Micafungin | Sagent Pharmaceuticals | 2022-09-15 |
| 25021-0190-12 | 20 VIAL in 1 CARTON (25021-190-12) / 5 mL in 1 VIAL | Micafungin | Sagent Pharmaceuticals | 2025-11-01 |
| 25021-0191-10 | 1 VIAL in 1 CARTON (25021-191-10) / 5 mL in 1 VIAL | Micafungin | Sagent Pharmaceuticals | 2021-06-15 |
| 25021-0191-11 | 10 VIAL in 1 CARTON (25021-191-11) / 5 mL in 1 VIAL | Micafungin | Sagent Pharmaceuticals | 2022-09-15 |
| 25021-0191-12 | 20 VIAL in 1 CARTON (25021-191-12) / 5 mL in 1 VIAL | Micafungin | Sagent Pharmaceuticals | 2025-11-01 |
| 42023-0229-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (42023-229-10) / 10 mL in... | Micafungin | Par Health USA, LLC | 2021-08-01 |
| 42023-0230-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (42023-230-10) / 10 mL in... | Micafungin | Par Health USA, LLC | 2021-08-01 |
| 42658-0022-01 | 1 VIAL in 1 BOX (42658-022-01) / 1 INJECTION, POWDER, FOR S... | Micafungin | Hisun Pharmaceuticals USA, Inc. | 2026-04-01 |
| 42658-0022-02 | 10 BOX in 1 CARTON (42658-022-02) / 1 VIAL in 1 BOX / 1 INJ... | Micafungin | Hisun Pharmaceuticals USA, Inc. | 2026-04-01 |
| 42658-0023-01 | 1 VIAL in 1 BOX, UNIT-DOSE (42658-023-01) / 1 INJECTION, PO... | Micafungin | Hisun Pharmaceuticals USA, Inc. | 2026-04-01 |
| 42658-0023-02 | 10 BOX in 1 CARTON (42658-023-02) / 1 VIAL in 1 BOX / 1 INJ... | Micafungin | Hisun Pharmaceuticals USA, Inc. | 2026-04-01 |
| 63323-0728-10 | 10 CARTON in 1 CARTON (63323-728-10) / 1 VIAL, SINGLE-DOSE... | Micafungin | Fresenius Kabi USA, LLC | 2020-05-08 |
| 63323-0729-10 | 10 CARTON in 1 CARTON (63323-729-10) / 1 VIAL, SINGLE-DOSE... | Micafungin | Fresenius Kabi USA, LLC | 2020-05-08 |
| 63323-0729-12 | 10 CARTON in 1 CARTON (63323-729-12) / 1 VIAL, SINGLE-DOSE... | Micafungin | Fresenius Kabi USA, LLC | 2020-05-08 |
| 67184-0589-01 | 1 VIAL in 1 CARTON (67184-0589-1) / 5 mL in 1 VIAL | MICAFUNGIN | Qilu Pharmaceutical Co., Ltd | 2025-04-03 |
| 67184-0589-02 | 10 VIAL in 1 CARTON (67184-0589-2) / 5 mL in 1 VIAL | MICAFUNGIN | Qilu Pharmaceutical Co., Ltd | 2025-04-03 |
| 67184-0590-01 | 1 VIAL in 1 CARTON (67184-0590-1) / 5 mL in 1 VIAL | MICAFUNGIN | Qilu Pharmaceutical Co., Ltd | 2025-04-03 |
| 67184-0590-02 | 10 VIAL in 1 CARTON (67184-0590-2) / 5 mL in 1 VIAL | MICAFUNGIN | Qilu Pharmaceutical Co., Ltd | 2025-04-03 |
| 68462-0771-01 | 1 VIAL in 1 CARTON (68462-771-01) / 5 mL in 1 VIAL | MICAFUNGIN | Glenmark Pharmaceuticals Inc., USA | 2025-06-30 |
| 68462-0771-10 | 10 VIAL in 1 CARTON (68462-771-10) / 5 mL in 1 VIAL | MICAFUNGIN | Glenmark Pharmaceuticals Inc., USA | 2025-06-30 |
| 68462-0772-01 | 1 VIAL in 1 CARTON (68462-772-01) / 5 mL in 1 VIAL | MICAFUNGIN | Glenmark Pharmaceuticals Inc., USA | 2025-06-30 |
| 68462-0772-10 | 10 VIAL in 1 CARTON (68462-772-10) / 5 mL in 1 VIAL | MICAFUNGIN | Glenmark Pharmaceuticals Inc., USA | 2025-06-30 |
| 70377-0075-91 | 10 VIAL, SINGLE-DOSE in 1 CARTON (70377-075-91) / 5 mL in 1... | MICAFUNGIN | Biocon Pharma Inc. | 2025-06-01 |
| 70377-0076-91 | 10 VIAL, SINGLE-DOSE in 1 CARTON (70377-076-91) / 10 mL in... | MICAFUNGIN | Biocon Pharma Inc. | 2025-06-01 |
| 70710-1724-01 | 1 VIAL in 1 CARTON (70710-1724-1) / 5 mL in 1 VIAL | Micafungin | Zydus Pharmaceuticals USA Inc. | 2024-08-20 |
| 70710-1724-06 | 10 VIAL in 1 CARTON (70710-1724-6) / 5 mL in 1 VIAL | Micafungin | Zydus Pharmaceuticals USA Inc. | 2023-04-10 |
| 70710-1725-01 | 1 VIAL in 1 CARTON (70710-1725-1) / 5 mL in 1 VIAL | Micafungin | Zydus Pharmaceuticals USA Inc. | 2024-08-20 |
| 70710-1725-06 | 10 VIAL in 1 CARTON (70710-1725-6) / 5 mL in 1 VIAL | Micafungin | Zydus Pharmaceuticals USA Inc. | 2023-04-10 |
| 70771-1683-01 | 1 VIAL in 1 CARTON (70771-1683-1) / 5 mL in 1 VIAL | Micafungin | Zydus Lifesciences Limited | 2024-08-20 |
| 70771-1683-06 | 10 VIAL in 1 CARTON (70771-1683-6) / 5 mL in 1 VIAL | Micafungin | Zydus Lifesciences Limited | 2023-04-10 |
| 70771-1684-01 | 1 VIAL in 1 CARTON (70771-1684-1) / 5 mL in 1 VIAL | Micafungin | Zydus Lifesciences Limited | 2024-08-20 |
| 70771-1684-06 | 10 VIAL in 1 CARTON (70771-1684-6) / 5 mL in 1 VIAL | Micafungin | Zydus Lifesciences Limited | 2023-04-10 |
| 71288-0028-11 | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-028-11) / 5 mL in 1... | Micafungin | Meitheal Pharmaceuticals Inc. | 2022-09-28 |
| 71288-0028-12 | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-028-12) / 5 mL in 1... | Micafungin | Meitheal Pharmaceuticals Inc. | 2024-11-01 |
| 71288-0029-11 | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-029-11) / 5 mL in 1... | Micafungin | Meitheal Pharmaceuticals Inc. | 2022-09-28 |
| 71288-0029-12 | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-029-12) / 5 mL in 1... | Micafungin | Meitheal Pharmaceuticals Inc. | 2024-11-01 |
Observed labelers:
Sagent Pharmaceuticals (6) ·
Glenmark Pharmaceuticals Inc., USA (4) ·
Hisun Pharmaceuticals USA, Inc. (4) ·
Meitheal Pharmaceuticals Inc. (4) ·
Qilu Pharmaceutical Co., Ltd (4) ·
Zydus Lifesciences Limited (4)
· +6 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J2248 | Micafungin sodium injection | 25 | CMS |
| J2247 | Inj, micafungin (par pharm) | 2 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.